Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10914847 | Molecular Oncology | 2014 | 13 Pages |
Abstract
Bone morphogenetic proteins (BMPs) are a group of growth factors with dual functions in cancer development and progression. Recently, certain tumor-promoting roles have been identified for selected antagonists/inhibitors (BMPIs) of this developmental pathway. A recent focus on the implication of BMP in colorectal cancer progression has emerged, mainly due to the presence of inactivating mutations in several members of the canonical signaling cascade. However, the detailed expression profiles of BMPIs remain largely unknown. Based on our previous work, whereby three specific BMPIs, gremlin-1 (GREM1), high-temperature requirement A3 (HTRA3) and follistatin (FST) were collectively overexpressed in desmoplastic cocultures of colorectal cancer (CRC), here, we undertook an immunohistochemical approach to describe the patterns of their expression in CRC patients. Two major characteristics described the BMPI expression signature: First, the synchronous and coordinated stromal and epithelial overexpression of individual BMPIs in desmoplastic lesions, which demonstrated that all three of them contribute to increasing levels of BMP antagonism in such areas. Second, the presence of microenvironmental polarity in the BMPI pattern of expression, which was indicated through the preferential expression of HTRA3 in the stromal, and the parallel FST/GREM1 expression in the epithelial component of the investigated sections. In addition, expression of HTRA3 in the epithelial compartment of the tumors demonstrated a significant predictive power to discriminate between tumor-budding-bearing and tumor-budding-free desmoplastic microenvironments. Together, these findings contribute to the understanding of signaling dynamics of BMP antagonism in the colorectal cancer desmoplastic invasion front.
Keywords
lamb1TGF-βh-caldesmonα-SMAβ-catGrem1FollistatinHtrA3ROCTBSMSIVEGFR2FSTNTBAUCα-smooth muscle actinImmunohistochemistryIHCβ-cateninTILMicrosatellite instabilitytransforming growth factor-βEMTTumor buddingColorectal cancerCancer-associated fibroblaststumor-infiltrating lymphocytearea under the curveepithelial-to-mesenchymal transitionGremlin-1Vascular endothelial growth factor receptor-2receiver operating characteristic
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
George S. Karagiannis, Ann Treacy, David Messenger, Andrea Grin, Richard Kirsch, Robert H. Riddell, Eleftherios P. Diamandis,